Here are four things to know:
1. As chief clinical officer, Dr. Garrett will lead the company’s clinical-related activities across the globe.
2. PENTAX Medical, a division of Hoya, opted to create this new role to speed up its offering of clinical relevant products aimed at enhancing patient care.
3. Specializing in infection control, Dr. Garrett will draw on his experience to ensure PENTAX Medical is working to reduce infection risks and cross contamination.
4. Dr. Garrett completed his infection control and hospital epidemiology fellowship at Johns Hopkins in Baltimore.
More articles on GI & endoscopy:
A colonoscopy is required for IBD patients once every 5 years — 5 points
Gastroenterologist to know: Dr. Christopher Forsmark of University of Florida
AGA, Takeda Pharmaceuticals U.S.A. to fund IBD research: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.